CRIS

Curis Inc. Common Stock (CRIS)

Stock · NASDAQ · Health Care

$1.49as of 8/28/2026

Active signals

High Beta100.0%
Resistance level
$10.04
Industry
Biotechnology: Biological Products (No Diagnostic Substances)

About CRIS

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small-molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single-arm expansion trial in patients with relapsed/refractory primary central nervous system lymphoma. The company's pipelin…

Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Employees
20

Fundamentals

1-day range
$1.45$1.58
Market cap
$10.04M
P/E (trailing)
P/E (forward)
-0.25
EPS (trailing)
$-10.99
Dividend yield
Beta
3.38
Avg. volume
283.3K
Dividend pay date
May 30, 2018
52-week range
$1.4$39
Next earnings: November 5, 2026 · EPS estimate $-2.01confirmed

How Curis Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$9.44MSG&A$14.05M (149%)CRIS

Source: 10-K filed Mar 24, 2026 · via SEC EDGAR / Finnhub

Forecasts

3 analyst ratings

Buy 90%
Hold 10%
Sell 0%
1-year price forecast
High
$65
+4262.4%
Median
$43
+2785.9%
Low
$20
+1242.3%

Curis Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • CRIS
    Curis Inc. Common Stock
    $1.49
    ▲ 2.76%
    Market cap $10.04MP/E
    $1.4$39
  • BCDA
    BioCardia Inc. Common Stock
    $1.16
    ▼ 0.85%
    Market cap $9.45MP/E
    $0.75$2.29
  • INTS
    Intensity Therapeutics Inc. Common stock
    $4.25
    ▲ 0.95%
    Market cap $11.51MP/E
    $3.51$43.5
  • SNTI
    Senti Biosciences Holdings Inc. Common Stock
    $0.377
    ▼ 0.26%
    Market cap $11.53MP/E
    $0.3305$2.88
  • AIM
    AIM ImmunoTech Inc. Common Stock
    $0.2558
    ▲ 2.32%
    Market cap $7.32MP/E
    $0.1901$2.89
  • PASG
    Passage Bio Inc. Common Stock
    $4.52
    ▲ 4.39%
    Market cap $14.40MP/E
    $3.29$20
  • BCAB
    BioAtla Inc. Common Stock
    $1.79
    ▼ 42.99%
    Market cap $5.41MP/E
    $2.81$71.5

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions
Acquired
450.7K
Disposed
150

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.